David Lowrance
2020
In 2020, David Lowrance earned a total compensation of $808.5K as Chief Financial Officer & Secretary at Mast Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,596 |
|---|---|
| Option Awards | $245,296 |
| Salary | $379,600 |
| Other | $22,000 |
| Total | $808,492 |
Lowrance received $379.6K in salary, accounting for 47% of the total pay in 2020.
Lowrance also received $161.6K in non-equity incentive plan, $245.3K in option awards and $22K in other compensation.
Rankings
In 2020, David Lowrance's compensation ranked 9,461st out of 13,090 executives tracked by ExecPay. In other words, Lowrance earned more than 27.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,461 out of 13,090 | 28th |
Division Manufacturing | 4,052 out of 5,621 | 28th |
Major group Chemicals And Allied Products | 1,648 out of 2,254 | 27th |
Industry group Drugs | 1,444 out of 1,954 | 26th |
Industry Pharmaceutical Preparations | 1,061 out of 1,459 | 27th |
Source: SEC filing on April 19, 2022.
Lowrance's colleagues
We found two more compensation records of executives who worked with David Lowrance at Mast Therapeutics in 2020.